Lixte Biotechnology Holdings Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -100.0% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -100.0% | – | – | – | – | – | – | – | – | – | |
| – | +87.1% | -37.8% | -64.1% | -91.3% | +1,916.8% | +49.1% | +41.9% | -22.3% | -33.4% | -19.1% | -64.9% | |
| – | -41.3% | +10.5% | +61.0% | +56.2% | -20.4% | +22.4% | +144.0% | -0.4% | -15.5% | -32.1% | +70.5% | |
| – | +18.4% | -25.0% | -15.2% | +18.1% | +16.5% | +31.2% | +105.7% | -6.1% | -19.3% | -29.8% | +43.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +18.2% | +134.6% | +651.4% | +258.0% | +910.0% | -92.6% | +101.8% | +19.7% | +82.9% | +3.6% | -45.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | -215.2% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.